Role of granulocyte colony stimulating factor in the treatment of cirrhosis of liver: a systematic review
Objective We performed a systematic review to analyze the benefits of and risk factors associated with granulocyte colony stimulating factor (GCSF) in patients with liver cirrhosis. Methods PubMed, Scopus, and Embase were searched for randomized controlled trials and case–control studies that compar...
Main Authors: | Siddheesh Rajpurohit, Balaji Musunuri, Pooja Basthi Mohan, Ganesh Bhat, Shiran Shetty |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-11-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605231207064 |
Similar Items
-
Is carvedilol superior to propranolol in patients with cirrhosis with portal hypertension: a systematic and meta-analysis
by: Siddheesh Rajpurohit, et al.
Published: (2025-02-01) -
Development and evaluation of patient information leaflet for liver cirrhosis patients
by: Siddheesh Rajpurohit, et al.
Published: (2023-11-01) -
Pill Esophagitis: Clinical and Endoscopic Profile
by: Vikas Pemmada, et al.
Published: (2023-12-01) -
Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis
by: Sahaj Rathi, et al.
Published: (2021-01-01) -
Granulocyte colony-stimulating factor and leukemogenesis
by: Lorena Lobo de Figueiredo, et al.
Published: (2004-01-01)